Presentation is loading. Please wait.

Presentation is loading. Please wait.

PATHOPHYSIOLOGY. NSAID use COX-1 inhibition ↓prostaglandins in the gastric mucosa ↓mucin secretion ↓HCO3 secretion ↑HCl secretion ↓epithelial cell proliferation.

Similar presentations


Presentation on theme: "PATHOPHYSIOLOGY. NSAID use COX-1 inhibition ↓prostaglandins in the gastric mucosa ↓mucin secretion ↓HCO3 secretion ↑HCl secretion ↓epithelial cell proliferation."— Presentation transcript:

1 PATHOPHYSIOLOGY

2 NSAID use COX-1 inhibition ↓prostaglandins in the gastric mucosa ↓mucin secretion ↓HCO3 secretion ↑HCl secretion ↓epithelial cell proliferation ↓mucosal blood flow Migrate across the lipid membrane of epithelial cells Ion trapping Direct epithelial cell toxicity Impairment of mucosal defense system

3 Disruption of mucosal integrity ULCERATION Ulcer burrow deeper into the gastric mucosa Injury to the blood vessels GI BLEEDING Melena Coffe-ground emesis Inhibition of TXA 2 ↓platelet aggregation NSAID use


Download ppt "PATHOPHYSIOLOGY. NSAID use COX-1 inhibition ↓prostaglandins in the gastric mucosa ↓mucin secretion ↓HCO3 secretion ↑HCl secretion ↓epithelial cell proliferation."

Similar presentations


Ads by Google